An engineered Plasmodium vivax Duffy binding protein (DBPII) vaccine bypasses DBP strain variability and has enhanced reactivity to naturally acquired long-term antibody responses
Immunity, pathogenesis and vaccine discovery and development
Vol.1, 2017 -
63859